Clinical Trials Browser

Phase 2 × Myasthenia Gravis × 30 days × Clear all

Myasthenia Gravis

NCT06414954 2026-03-10

SYNAPSE-MG

Phase 2 Recruiting

84 enrolled

Myasthenia Gravis

NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Phase 2 Active not recruiting

53 enrolled

CNS

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

Clinical Trials

THYME

SYNAPSE-MG

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases